Fecal microbiota transplantation as an effective therapeutic alternative

Juliana Stupnik and Gerardo Laube

South Health and Policy, 2024, vol. 3, 145-145

Abstract: Antibiotic-associated diarrhoea was a common complication of antimicrobial treatment, mainly caused by an imbalance in the gut microbiota. Clostridioides difficile was identified as the most frequent causative agent, capable of triggering pseudomembranous colitis, especially in vulnerable patients. Given the high recurrence rates of conventional treatments, faecal microbiota transplantation was evaluated as an effective therapeutic alternative. This procedure involved transferring faecal material from a healthy donor to an affected recipient, achieving remarkable restoration of intestinal balance, reduced mortality, and significant clinical improvement. In addition to its efficacy, a favourable safety profile and reduced healthcare costs were documented, consolidating it as a key tool in the treatment of recurrent C. difficile infections.

Date: 2024
References: Add references at CitEc
Citations:

There are no downloads for this item, see the EconPapers FAQ for hints about obtaining it.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:dbk:southh:2024v3a74

DOI: 10.56294/shp2024145

Access Statistics for this article

More articles in South Health and Policy from AG Editor (Argentina)
Bibliographic data for series maintained by Javier Gonzalez-Argote ().